AGP Picks
View all

Good Morning! Latin America
Provided by AGP

Good Morning! Latin America: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Good Morning! Latin America.

March 2026

Mo Tu We Th Fr Sa Su
1
2 3 4 5 6 7 8
9 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

Press releases published on May 27, 2026

AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration
May 27, 2026

AIM ImmunoTech Announces Emerging Ebola Opportunity for Ampligen Amid Escalating Global Health Concerns and WHO Emergency Declaration

Indeterminate GlobeNewswire
Altimmune to Participate in Upcoming Investor Conferences
May 27, 2026

Altimmune to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire
EOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer Patients
May 27, 2026

EOM Pharmaceutical Holdings Reports FDA Clearance of an IND for a Clinical Trial in Cachectic Cancer Patients

Indeterminate GlobeNewswire
Pan American Completes Logging and Sampling from Initial Drill Program at Tharsis Project
May 27, 2026

Pan American Completes Logging and Sampling from Initial Drill Program at Tharsis Project

Indeterminate GlobeNewswire
Avalyn to Participate in the Jefferies Global Healthcare Conference
May 27, 2026

Avalyn to Participate in the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference
May 27, 2026

Cogent Biosciences Announces Participation in the 2026 Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis
May 27, 2026

Rectify Pharmaceuticals Presents New Translational Data at EASL 2026 Supporting RTY-406, its Clinical Candidate for the Treatment of Primary Sclerosing Cholangitis

Indeterminate GlobeNewswire
SONORO GOLD ANNOUNCES CHANGE OF AUDITOR
May 27, 2026

SONORO GOLD ANNOUNCES CHANGE OF AUDITOR

Indeterminate GlobeNewswire
Micron Biomedical Expands Leadership to Mobilize for Pivotal Studies and Commercialization of First Needle-Free Dissolvable Vaccines and Therapeutics
May 27, 2026

Micron Biomedical Expands Leadership to Mobilize for Pivotal Studies and Commercialization of First Needle-Free Dissolvable Vaccines and Therapeutics

Indeterminate GlobeNewswire
Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity
May 27, 2026

Enlivex Treasury Portfolio Update: Rain Protocol Jumps Into Top Three Global Prediction Markets In League Table Following $100M In Additional Liquidity

Indeterminate GlobeNewswire
New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026
May 27, 2026

New IMPACT Phase 2b Data Highlight Concurrent Improvements Across Multiple Non-Invasive Markers and qFibrosis-Measured Fibrosis Regression with Pemvidutide in MASH at EASL 2026

Indeterminate GlobeNewswire
NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes
May 27, 2026

NewCelX Ltd. Submits Pre-IND Package to the FDA for NCEL-101 for the Treatment of Type 1 Diabetes

Indeterminate GlobeNewswire
Transforming Rural Health Care Through a First-of-its-Kind Collaborative
May 27, 2026

Transforming Rural Health Care Through a First-of-its-Kind Collaborative

Indeterminate GlobeNewswire
BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9
May 27, 2026

BridgeBio Announces FDA Acceptance and Priority Review of NDA for BBP-418 for LGMD2I/R9

Indeterminate GlobeNewswire
Context Therapeutics to Present at the Jefferies Global Healthcare Conference
May 27, 2026

Context Therapeutics to Present at the Jefferies Global Healthcare Conference

Indeterminate GlobeNewswire
Morocco Strategic Minerals Corp. Enters Agreement to Sell Sakami Property in Québec
May 27, 2026

Morocco Strategic Minerals Corp. Enters Agreement to Sell Sakami Property in Québec

Indeterminate GlobeNewswire
Corporation de Minéraux Stratégiques du Maroc conclut une entente pour la vente de la propriété Sakami au Québec
May 27, 2026

Corporation de Minéraux Stratégiques du Maroc conclut une entente pour la vente de la propriété Sakami au Québec

Indeterminate GlobeNewswire
Goliath Resources Mobilizes For A Fully Funded 50,000 Meter Expansion Drill Program On Surebet Discovery, Golden Triangle, B.C.
May 27, 2026

Goliath Resources Mobilizes For A Fully Funded 50,000 Meter Expansion Drill Program On Surebet Discovery, Golden Triangle, B.C.

Indeterminate GlobeNewswire
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
May 27, 2026

Maze Therapeutics to Participate in Two Upcoming Investor Conferences

Indeterminate GlobeNewswire
Invivyd to Participate in Upcoming Investor Events
May 27, 2026

Invivyd to Participate in Upcoming Investor Events

Indeterminate GlobeNewswire
Show More

Share this page:

Sign up for:

Good Morning! Latin America

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.